The tobacco mitogen-activated protein kinase (MAPK) cascade, which includes MAPK NRK1/NTF6, positively regulates expansion of the cytokinetic machinery known as the phragmoplast, which is followed by the synthesis of cell plates for completion of cell division. However, molecular events lying between the MAPK and phragmoplast expansion were not known. Here, we show that NRK1/NTF6 phosphorylates the threonine residue at position 579 in NtMAP65-1a, a microtubule-associated (MT-associated) protein. Levels of phosphorylated NtMAP65-1 increase during late M phase of the cell cycle, when NRK1/NTF6 is activated. Phosphorylated NtMAP65-1 is concentrated at the equator of phragmoplast, as is NRK1/NTF6. Overexpression of mutant forms of NtMAP65-1a that cannot be phosphorylated by NRK1 delays progression of the M phase and phragmoplast expansion, also rendering phragmoplast structures resistant to an MT-depolymerizing drug. Phosphorylation of NtMAP65-1 by NRK1/NTF6 down-regulates its MT-bundling activity in vitro. These results suggest that phosphorylation of NtMAP65-1 by NRK1/NTF6 also reduces its MT-bundling activity in vivo, which enhances destabilization and turnover of MTs at the phragmoplast equator, perhaps facilitating phragmoplast expansion.
). Members of this family are concentrated at the midzone of the central spindle and the phragmoplast during cytokinesis, and their appropriate organization seems to be required for completion of cytokinesis (Pellman et al. 1995; Juang et al. 1997; Jiang et al. 1998; Mollinari et al. 2002; Schuyler et al. 2003; Müller et al. 2004; Verbrugghe and White 2004; Vernì et al. 2004) . PRC1 is phosphorylated by cyclin-dependent protein kinases (CDKs), and overexpression of a mutant form of PRC1 that cannot be phosphorylated by CDKs results in the bundling of the MTs of the metaphase spindle and interruption of the progression from metaphase to anaphase, suggesting that phosphorylation of PRC1 by CDKs is required for the metaphase-to-anaphase transition (Mollinari et al. 2002) . Phosphorylation of AtMAP65-1 by CDKs might also regulate the targeting of MAP65 to phragmoplast MTs (Mao et al. 2005) . However, the ways in which MAP65 proteins control cytokinetic processes, after the inactivation of CDKs at the metaphase-to-anaphase transition, remain to be characterized.
The NACK-PQR pathway, a mitogen-activated protein kinase (MAPK) cascade that is required for plant cytokinesis, is activated during late M phase and conserved in both tobacco and Arabidopsis. This pathway consists of NACK1, NACK2, kinesin-like proteins (KLPs), NPK1 (nucleus-and phragmoplast-localized protein kinase 1) MAPK kinase kinase (MAPKKK), NQK1/ NtMEK1 MAPK kinase (MAPKK), and NRK1/NTF6 MAPK in tobacco, and NPK1 is activated by direct binding to NACK1 Ishikawa et al. 2002; Soyano et al. 2003) . During cytokinesis, NACK1, NPK1, NQK1/NtMEK1, and NRK1/NTF6 are found at the equatorial zone of the phragmoplast (Calderini et al. 1998; Nishihama et al. , 2002 our unpublished data) . Our recent studies have demonstrated that the NACK-PQR pathway is required for cytokinesis and, in particular, for the expansion of the phragmoplast, and its functions appear to be related to the stability of phragmoplast MTs Ishikawa et al. 2002; Soyano et al. 2003) .
AtNACK1/HINKEL, ANP1 (ANP2 and ANP3), and ANQ1/AtMKK6 genes of Arabidopsis, which are orthologs of the tobacco NACK1, NPK1, and NQK1 genes, respectively, are also required for cytokinesis of Arabidopsis cells (Nishihama et al. 1997 Krysan et al. 2002; Strompen et al. 2002; Soyano et al. 2003; Tanaka et al. 2004 ). On the basis of these results, it has been proposed that these factors might control a certain event related to MTs. It is now important to identify factors that act downstream of the NACK-PQR pathway to understand the mechanisms that control cytokinesis.
We report here that NtMAP65-1, a member of the MAP65 family in tobacco, is phosphorylated by NRK1/ NTF6 MAPK and that NRK1-phosphorylated NtMAP65-1 is concentrated at the phragmoplast equator, as is NRK1/ NTF6. Overexpression, in tobacco cells, of a mutant form of NtMAP65-1a that cannot be phosphorylated by NRK1 delayed M-phase progression and expansion of the phragmoplast and increased the stability of MTs, suggesting that phosphorylation of NtMAP65-1 by NRK1/ NTF6 MAPK suppresses the ability of NtMAP65-1 to bundle MTs. Phosphorylation by NRK1 also decreased the MT-bundling activity of NtMAP65-1a in vitro. We propose that the NACK-PQR pathway can enhance destabilization of MTs and MT turnover at the midzone of the phragmoplast via phosphorylation of NtMAP65-1 during cytokinesis, which may positively stimulate phragmoplast expansion.
Results

NRK1/NTF6 MAPK phosphorylates NtMAP65-1a in vitro
Tobacco MT-associated proteins (MAPs), which had been partially purified from tobacco suspension-cultured BY-2 cells, were fractionated by anion-exchange column chromatography. Each fraction was subjected to a kinase assay in vitro with or without activated recombinant histidine-and T7-epitope-tagged NRK1 MAPK (His-T7-NRK1) in the presence of [␥-32 P]ATP. Two phosphorylated proteins were detected in fractions 24-29 (Fig. 1A) . Both proteins were identified as NtMAP65-1a by amino acid sequencing analysis, which suggested that they were derived from the same product of translation.
We performed an immunocomplex kinase assay using recombinant His-T7-NtMAP65-1a as the substrate. BY-2 cells were synchronized at prometaphase by two-step synchronization with aphidicolin and propyzamide, an MT-depolymerizing drug, and the cell cycle was allowed to proceed by removal of propyzamide. As shown in Figure 1B, panel b, the strongest phosphorylation of His-T7-NtMAP65-1a was detected in extracts of BY-2 cells prepared 0.5-1 h after the removal of propyzamide (top panel), namely, at late M phase. The timing of the phosphorylation of NtMAP65-1a by endogenous NRK1/ NTF6 was similar to that of the activation of NPK1 MAPKKK, NQK1/NtMEK1 MAPKK, and NRK1/NTF6 MAPK, as reported previously Soyano et al. 2003) . In contrast to the phosphorylation by NRK1, the strongest phosphorylation by CDKs, which had been prepared using p13 suc1 beads from the same extracts of BY-2 cells, was observed at 0 h (prometaphase), and the extent of phosphorylation fell gradually during progression of the cell cycle (Fig. 1B, panel b , middle).
NRK1/NTF6 MAPK phosphorylates a single threonine residue at position 579 in NtMAP65-1a
We generated several series of truncated NtMAP65-1a proteins and performed kinase assays in vitro with active recombinant NRK1 or CDKs. Only peptides that included the C-terminal fragment of NtMAP65-1a, from residue 352 to residue 580, were phosphorylated by NRK1 and CDKs in vitro (data not shown). There are four potential target sequences for phosphorylation (S/ TP) by MAPK and CDKs in this fragment (threonine residues at positions 501 and 579 and serine residues at positions 503 and 576, designated respectively) . We generated mutant NtMAP65-1a proteins, in which these residues were replaced by alanine residues in various combinations, and examined whether these mutants were phosphorylated by NRK1 or CDKs in vitro. The recombinant NtMAP65-1a proteins were phosphorylated efficiently by NRK1, and all of the proteins were estimated to be phosphorylated under conditions we used (data not shown). The protein with a mutation at Thr-579 (MAP65:T579A) and the doubly mutated protein with mutations at Thr-501 and Ser-503 (MAP65:T501A;S503A) in His-T7-NtMAP65-1a were not phosphorylated by NRK1 and by CDKs, respectively (Fig. 1C, panel a) . These results demonstrated that NtMAP65-1a has a single site for phosphorylation by NRK1/NTF6 MAPK-namely, Thr-579-and that Thr-501 and Ser-503 can be phosphorylated by CDKs (Fig. 1C, panel b) .
Phosphorylation of Thr-579 of NtMAP65-1 in vivo
We prepared antibodies against NtMAP65-1a that had been phosphorylated at Thr-579 (anti-pT579MAP65) and nonphosphorylated NtMAP65-1a (anti-MAP65). AntipT759MAP65 detected only NRK1-phosphorylated His-T7-NtMAP65-1a, and anti-MAP65 antibodies detected both phosphorylated and nonphosphorylated His-T7-NtMAP65-1a proteins ( Fig. 2A, panel a) . CDK-phosphorylated His-T7-NtMAP65-1a was not recognized by anti-pT579MAP65 (data not shown). Tobacco has at least three members of the MAP65-1 subfamily (namely, , which are >85% identical in terms of amino acid sequences to one another . Our anti-pT579MAP65 recognized all three NRK1-phosphorylated tobacco proteins to similar extents ( Supplementary Fig. 1 ), but not NRK1-phosphorylated AtMAP65-1, AtMAP65-2, and AtMAP65-3, which have putative MAPK-phosphorylation site (data not shown). In addition, antipT579MAP65 detected a single protein of ∼65 kDa in extracts of BY-2 cells, the estimated molecular mass of NtMAP65-1a, NtMAP65-1b, and NtMAP65-1c ( Fig. 2A,  panel b ). It appears that anti-pT579MAP65 is specific for phosphorylated forms of the NtMAP65-1 subfamily in tobacco.
We examined the phosphorylation of NtMAP65-1 at Thr-579 during the M phase using our antibodies. We prepared protein extracts of BY-2 cells that had been synchronized by the two-step procedure with aphidicolin and propyzamide, and subjected them to Western blotting analysis with anti-pT579MAP65 and anti-MAP65. Both antibodies recognized a single protein of 65 kDa ( Fig. 2A, panel b , middle and bottom). After removal of propyzamide, the level of NtMAP65-1-P 579 rose from 0.5 to 1 h and fell to the background level at 4 h ( Fig. 2A,  panel b, bottom) , although the level of NtMAP65-1 was invariable ( Fig. 2A, panel b, middle) . This increase in We examined the subcellular localization of NtMAP65-1 and of NtMAP65-1-P 579 during the M phase by immunostaining (Fig. 2B ). Anti-MAP65 bound to all cytoskeletal structures throughout mitosis, including preprophase bands, spindles, and phragmoplasts (Fig. 2B, panel a) . Experiments with green fluorescent protein-fused NtMAP65-1a (GFP-NtMAP65-1a) yielded essentially the same results (data not shown). Patterns of signals due to anti-pT579MAP65 were basically similar to those due to anti-MAP65 from interphase to metaphase (Fig. 2B, panel b ). Signals were, however, concentrated in the midzone of early phragmoplasts at anaphase (Fig. 2B, panel b; anaphase) . From telophase to late telophase, signals were localized at the phragmoplast equator (Fig. 2B , panel b; telophase and late telophase). Thus, NtMAP65-1-P 579 was concentrated at the equatorial region of the phragmoplast during its lateral expansion, consistent with localization of components in the NACK-PQR cascade (Calderini et al. 1998; Bögre et al. 1999; Nishihama et al. 2002; our unpublished data) .
Expression of MAPK-nonphosphorylatable NtMAP65-1a delays the cell cycle
We postulated that overexpression of NRK1-nonphosphorylatable NtMAP65-1a might affect cell division by dominant-negative interference with the activity of Thr-579-phosphorylated NtMAP65-1a. We transformed BY-2 cells with cDNA constructs for GFP-fused NtMAP65-1a (MAP65:WT) and various mutants of NtMAP65-1a, under the control of a dexamethasone-inducible (DEX-inducible) transcription system (Aoyama and Chua 1997) . In MAP65:T579A, MAP65:T501A;S503A, and MAP65: T501A;S503A;T579A, the sites of phosphorylation by NRK1, CDKs, and both kinases were replaced, respectively, by nonphosphorylatable alanine residues (Fig. 1C,  panel b) .
As shown in Figure 3A , when we synchronized BY-2 cells using aphidicolin, subsequent progression of the cell cycle in cells that expressed the cDNA for MAP65:T579A or the cDNA for MAP65:T501A;S503A; T579A in response to DEX was significantly delayed (Fig. 3A, panels c,e) . Peaks of mitotic indices were evident 10-12 h after removal of aphidicolin. By contrast, the cell cycle of cells that expressed the vector cDNA, the cDNA for MAP65:WT, or the cDNA for MAP65: T501A;S503A with mutations at CDK-phosphorylation sites was normal, with peaks of mitotic indices at 8 h (Fig. 3A, panels a,b,d ). The delay seemed to be caused by a reduced rate of progression of the M phase rather than a delay in the initiation of this phase because there were no differences in timing of the entry into M phase 6 h after the removal of aphidicolin (Fig. 3A) . Analysis by flow cytometry showed that the timing of progression from the S phase to G 2 was similar in all cell lines (data not shown).
We monitored expansion of phragmoplast in cells that harbored the GFP-fused MAP65:WT or GFP-fused MAP65:T579A construct (Fig. 3B ). In the presence of DEX, MAP65:WT and MAP65:T579A were found similarly on the phragmoplast, and so we were able to monitor expansion of the phragmoplast in terms of fluorescence derived from GFP-fused MAP65:WT and GFPfused MAP65:T579A. In BY-2 cells that expressed MAP65:WT, most phragmoplasts were fully expanded within 60 min after the initiation of phragmoplast formation (Fig. 3B, panel a, top) . By contrast, a significant proportion of BY-2 cells that expressed MAP65:T579A had different profiles. Although phragmoplasts were formed, many failed to reach the edges of cells within 90 min (Fig. 3B, panel a, bottom) . Ratios of the "length" of the fluorescent region to the width of the cell revealed clearly that expansion of the fluorescent region in MAP65:T579A cells was slower than that in MAP65:WT cells (Fig. 3B, panel b) . Thus, overexpression of NRK1-nonphosphorylatable NtMAP65-1a delayed expansion of the phragmoplast, suggesting that the low rate of phragmoplast expansion was responsible, at least in part, for the delayed progression of the M phase described above. The similar delayed expansion is observed when cDNAs for dominant-negative mutants of NACK1, NPK1, and NQK1 were overproduced Soyano et al. 2003) .
Phosphorylation of NtMAP65-1a at Thr-579 destabilizes the organization of MTs in vivo
We examined whether phosphorylation of NtMAP65-1a by NRK1/NTF6 MAPK might affect MT arrays in vivo. We transformed BY-2 cells with cDNAs for various DEXinducible proteins, namely, GFP-MAP65:WT, GFP-MAP65:T579A, GFP-MAP65:T501A;S503A, and GFP-MAP65:T501A;S503A;T579A, and then we examined the localization of these proteins in transformed cells. Figure 4A shows the fluorescence due to GFP in living transformed cells in the presence of DEX. In the absence of propyzamide, GFP-MAP65 was localized on cortical MTs during interphase, and there were no visible difference between the mutant and the wild-type proteins (Fig.  4A, top) . By contrast, there was a clear difference between cells that expressed GFP-MAP65:T579A (Fig. 4A , lower right panel) and the cells that expressed GFP-MAP65:WT (Fig. 4A, lower left panel) , in the presence of propyzamide. In cells that expressed GFP-MAP65:WT, signals had diffused into the cytoplasm, while in the cells that expressed GFP-MAP65:T579A, fluorescence due to GFP was detected on conspicuously bundled MTs.
Next, we investigated the stability of MT-containing structures using tubulin-specific antibodies (anti-tubulin). As shown in Figure 4B , cortical MTs and phragmoplasts were disrupted after treatment with 3 µM propyzamide in cells that expressed GFP-MAP65:WT or GFP-MAP65:T501A;S503A, and the cells became swollen, perhaps because of the disruption of cortical MTs. Moreover, many cells had poorly aligned chromosomes, and the cell cycle appeared to be arrested at prometaphase (Fig. 4B , third row of panels from top, left, and centerright). Cells expressing GFP-MAP65:T579A and GFP-MAP65:T501A;S503A;T579A, by contrast, retained well-organized MTs even after treatment with propyzamide, although the integrity of MTs seemed to be altered. At M phase, some of the cells were multinucleate with an incomplete phragmoplast (Fig. 4B , third and bottom rows of panels, center-left, and right), suggesting that the M phase had somehow progressed in these cells, even in the presence of propyzamide. Although these cells were elongated in the longitudinal direction, no lateral swelling was observed. Disruption of MTs by propyzamide was evident in all cell lines in the absence of DEX (data not shown). Thus, in cells that expressed NRK1-nonphosphorylatable NtMAP65-1a, arrays of at least the cortical MTs and the MTs of the phragmoplast were more resistant to propyzamide than they were in cells that expressed other constructs. These observations suggest that NRK1-nonphosphorylatable NtMAP65-1a enhances the stability of MT arrays in cortical MTs and the phragmoplast in vivo.
Phosphorylation of Thr-579 in NtMAP65-1a reduces its MT-bundling activity in vitro
The His-T7-NtMAP65-1a (MAP65:WT) protein that we prepared from Escherichia coli bound to MTs (data not 
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Cold Spring Harbor Laboratory Press on August 27, 2017 -Published by genesdev.cshlp.org Downloaded from shown) and bundled MTs in vitro (Fig. 5A) . We examined the effects of the phosphorylation of NtMAP65-1a by NRK1 and/or CDKs on its bundling activity. When NRK1-phosphorylated MAP65:WT was added at concentrations of 0.1 µM and lower, the bundling of MTs was less prominent than it was when nonphosphorylated MAP65:WT was added at the same respective concentrations (Fig. 5A) . When both types of NtMAP65-1a protein were added at 0.5 µM, no difference was observed between their effects.
To quantitate the relative efficiencies of MT bundling by NtMAP65-1a proteins, we performed a cosedimentation assay with low-speed centrifugation, anticipating that nonbundled MTs and bundled MTs would be recovered in the supernatant and pellet, respectively. We subjected such supernatants and pellets to SDS-PAGE, and stained gels with Coomassie brilliant blue (Fig. 5B, panel  a) . Then we calculated relative levels of tubulin in pellet fractions and plotted our results (Fig. 5B, panel b) . Under our conditions, most of the tubulin was recovered in the supernatant fraction in the absence of NtMAP65, while most of the tubulin was recovered in the pellet fraction in the presence of 0.3 µM MAP65:WT (Fig. 5B, panel a,  lanes 1,2) .
As shown in Figure 5B , NRK1-phosphorylated proteins were less-efficient mediators of MT bundling at concentrations of 0.15 µM and lower than nonphosphorylated NtMAP65-1a. In contrast to phosphorylation by NRK1, phosphorylation of NtMAP65-1a by CDKs only slightly suppressed the bundling of MTs by NtMAP65-1a (Fig.  5B) . When NtMAP65-1a was phosphorylated by both NRK1 and CDKs together, there was no synergistic effect on the suppression of MT bundling (Fig. 5B) . When we treated NRK1-nonphosphorylatable NtMAP65-1a (MAP65:T579A) with NRK1, its ability to bundle MTs was the same as that of NtMAP65:T579A without treatment with NRK1 (Fig. 5B, panel a, lanes 9-12) . These results showed that the decrease in the MT-bundling activity of NtMAP65-1a in vitro was mainly due to phosphorylation by NRK1 MAPK. Note that the phosphorylation of NtMAP65-1a by NRK1 and by CDKs did not affect the ability of NtMAP65-1a to bind to MTs (data not shown).
Discussion
The present study has demonstrated that tobacco NRK1/ NTF6 MAPK phosphorylates NtMAP65-1, and that such phosphorylation down-regulates the MT-bundling activity of NtMAP65-1 and stimulates progression of cytokinesis of tobacco cells. Thus, we linked the NACK-PQR MAPK pathway to phragmoplast expansion through the regulatory function of NtMAP65-1.
Phosphorylation of Thr-579 in NtMAP65-1a by NRK1/NTF6 MAPK is a key reaction in the control of cytokinesis
We showed here that NRK1/NTF6 MAPK phosphorylates NtMAP65-1a directly at Thr-579 in vitro (Fig. 1) . We have also provided evidence for such phosphorylation in vivo, as follows: (1) The level of the phosphorylated members of the NtMAP65-1 subfamily, as detected with phospho-Thr-579-specific antibodies, increased at late M phase, when NRK1/NTF6 MAPK is activated ( MTs with His-T7-NtMAP65-1a and individual MTs were separated by low-speed centrifugation. Aliquots of supernatants (S), which included nonbundled MTs and pellets (P) that included bundled MTs, were subjected to SDS-PAGE and then the gel was stained. (Panel b) Graphs showing ratios of bundled MTs to total MTs at various concentrations of His-T7-NtMAP65-1a (MAP65:WT). Relative amounts of MTs that had been bundled by MAP65:WT (open squares), NRK1-phosphorylated proteins (red filled squares), CDK-phosphorylated proteins (open diamonds), and NRK1 plus CDK-phosphorylated proteins (blue filled diamonds) were calculated from the results of cosedimentation assays after low-speed centrifugation. Independent assays were performed more than three times, and average values with standard deviations are shown. 2A). (2) Phosphorylated forms of NtMAP65-1 were concentrated at the equatorial region of phragmoplasts, at which NRK1/NTF6 is also concentrated, although nonphosphorylated form(s) were present over the entire phragmoplast (Fig. 2B) , as was GFP-fused NtMAP65-1a (Sasabe et al. 2006) . (3) Overexpression of NRK1-nonphosphorylatable mutants of NtMAP65-1a delayed progression of the M phase and expansion of the phragmoplast (Fig. 3) . Such mutant NtMAP65-1a might have had a dominant inhibitory effect on the actions of endogenous phosphorylated MAP65-1a and/or other members of the MAP65-1 subfamily, because they bound to MTs in vivo and in vitro as avidly as the wild-type protein and were distributed similarly to the wild-type protein in BY-2 cells (our unpublished data). We showed previously that dominant-negative mutations in components of this MAPK cascade-namely, NACK1, NPK1, and NQK1-inhibited expansion of the phragmoplast Soyano et al. 2003) . Therefore, the results of our experiments in vivo suggest that Thr-579 of NtMAP65-1a is phosphorylated in vivo by NRK1/NTF6 MAPK, which is localized at the phragmoplast equator and positively regulates progression of the M phase and cytokinesis.
Members of the MAP65 protein family are required for cytokinesis in human, Drosophila, and Arabidopsis (Jiang et al. 1998; Mollinari et al. 2002; Müller et al. 2004; Vernì et al. 2004 ). Thus, our data suggest that phosphorylation of Thr-579 in NtMAP65-1 by NRK1/NTF6 MAPK is a key reaction that controls the functions of NtMAP65-1a during cytokinesis. Various members of the MAP65 family are concentrated at the phragmoplast in a variety of plants (Smertenko et al. 2000 Müller et al. 2004; Van Damme et al. 2004a ). Both AtMAP65-1 and AtMAP65-2 of Arabidopsis, which are the most strongly homologous to members of the tobacco NtMAP65-1 family among MAP65 isotypes, and AtMAP65-3 are also phosphorylated by NRK1/NTF6 (our unpublished data). It will be of interest to examine whether the functions of other MAP65 members are also regulated by NRK1/NTF6 or other MAPKs.
It is noteworthy that Thr-579-phosphorylated NtMAP65 was consistently detected throughout the cell cycle in BY-2 cells, even though NRK1/NTF6 is activated only at late M phase ( Fig. 2B ; our unpublished data). Member(s) of the MAP65-1 subfamily might also be phosphorylated by as yet unidentified MAPKs. Overexpression of the NRK1-nonphosphorylatable mutant of MAP65-1a, however, only affected progression of the M phase and cytokinesis (Fig. 3) . Phosphorylation of Thr-579 of NtMAP65-1 by NRK1/NTF6 MAPK seems to play a more critical role during the M phase than that during other phases.
Overexpression of CDK-nonphosphorylatable mutants of NtMAP65-1a does not affect the progression of the cell cycle
Recombinant NtMAP65-1a protein was phosphorylated in vitro by CDKs prepared from BY-2 cells at M phase (Fig. 1) . However, overexpression of CDK-nonphosphorylatable mutants of NtMAP65-1a did not affect the progression of the cell cycle at any phase (Fig. 3) nor did it affect MT-bundling activity (Fig. 5B) . Our results are consistent with those obtained with AtMAP65-1 by Mao et al. (2005) . By contrast, overexpression of CDK-nonphosphorylatable PRC1 (a mammalian MAP65 homolog) in human cells resulted in cell cycle arrest (Mollinari et al. 2002) , indicating that progression of the cell cycle requires phosphorylation of PRC1 by CDK. As demonstrated in the present study, the control of MAP65 activity by NRK1/NTF6 MAPK appears to be crucial for plant cytokinesis, perhaps because expansion of the phragmoplast, which consists of huge bundles of MTs, must occur after the inactivation of CDKs at metaphase. It must be interesting to investigate the involvement of MAPKs in the regulation of MAP65 family in cytokinesis of animal cells.
MAPK might accelerate expansion of the phragmoplast via phosphorylation of NtMAP65-1 during cytokinesis
As discussed above, phosphorylation in vivo of Thr-579 of NtMAP65-1 by NRK1/NTF6 seems to enhance progression of the M phase. What molecular events might be regulated by such phosphorylation in vivo? Our results provide some information that might help to answer this question. Members of the MAP65 family might play a role in the maintenance of the central spindle in animals (Jiang et al. 1998; Mollinari et al. 2002; Verbrugghe and White 2004; Vernì et al. 2004 ) and the phragmoplast in plants during cytokinesis (Smertenko et al. 2000; Müller et al. 2004) . Some members might also be involved in the bundling of MTs in vivo to stabilize and maintain functional central spindles or phragmoplasts (Fig. 6, left; Mollinari et al. 2002; Müller et al. 2004; Van Damme et al. 2004b; Verbrugghe and White 2004; Vernì et al. 2004 ). The NRK1-nonphosphorylatable NtMAP65-1a rendered the phragmoplast and cortical MTs strongly resistant to depolymerization by propyzamide (Fig. 4) . In addition, we found that phosphorylation by NRK1/NTF6 decreased the MT-bundling activity of NtMAP65-1 in vitro (Fig. 5) . These results suggest that the stability of MTs depends on the MT-bundling activity of MAP65. Therefore, the simplest model that explains the molecular effects of phosphorylation by NRK1/NTF6 MAPK is that such phosphorylation suppresses the bundling activity of NtMAP65-1 in vivo. Phosphorylation of Nt-MAP65-1 at the phragmoplast midzone might untangle the highly bundled phragmoplast MTs and the resultant relaxed MTs at the phragmoplast midzone might then allow expansion of the phragmoplast, most probably via indirectly enhanced turnover of MTs (Fig. 6, right) .
Proteins outside the MAP65 family that are involved in stabilization of the phragmoplast or the central spindle have been identified in plants and animals (Williams et al. 1995; Whittington et al. 2001; Mishima et al. 2002; Twell et al. 2002) . In addition, mammalian PRC1 interacts separately with many proteins that are involved in the formation of the midzone of the central spindle (Ban et al. 2004; Kurasawa et al. 2004; Zhu and Jiang 2005) , suggesting that regulation of the dynamics of MT-containing structures must be very complex. Further investigations of MAP65-interacting proteins and identification of target proteins, other than MAP65s, in the NACK-PQR pathway are required if we are to understand fully the regulation of cytokinesis by this kinase cascade.
Materials and methods
Plant materials and transformation
Tobacco suspension-cultured BY-2 cells were maintained as described elsewhere . Synchronization of the BY-2 cell cycle at the G 1 /S boundary and two-step synchronization at prometaphase were performed as described previously (Banno et al. 1993; . Transformed BY-2 cells were generated by Agrobacterium-mediated transformation (An 1985) .
Preparation of MAPs from BY-2 cells
MAPs were prepared as described by Igarashi et al. (2000) . MAPs were fractionated on a Resource Q column (Amersham Bioscience) with a linear gradient of 0 to 1 M NaCl and desalted with the Microcon YM-10 system (Millipore).
Identification of amino acid sequences and isolation of cDNA for NtMAP65-1a
Bands of protein were cut from gels after SDS-PAGE. Proteins were digested with lysyl endopeptidase in situ and analyzed by automated protein sequencing. The technique confirmed that the proteins in the chosen bands were identical to NtMAP65-1a. To clone cDNA for NtMAP65-1a, we purified poly(A) + RNAs from BY-2 cells as described elsewhere (Banno et al. 1993) . We synthesized cDNA for NtMAP65-1a with specific primers from poly(A) + RNAs and cloned the cDNA in pENTR 3C (Invitrogen). Details of the primers are available from the authors upon request.
Site-directed mutagenesis and construction of plasmids
Mutations in NtMAP65-1a at putative sites of phosphorylation by MAPK and/or CDKs were introduced with a QuikChange Multi Site-Directed Mutagenesis Kit (Stratagene). All reactions were performed according to manufacturer's instructions.
Kinase assays in vitro and immunocomplex and p13 suc1 beads complex kinase assays
To obtain active NRK1 MAPK, we incubated recombinant His-T7-NRK1 and recombinant GST-NQK in kinase buffer ) plus 500 µM ATP for 60 min at 25°C and purified on a column of Chelating Sepharose FF (Amersham Biosciences) to eliminate GST-NQK1. Immunocomplex kinase assays were performed as described previously Soyano et al. 2003; Araki et al. 2004 ).
Production of antibodies and immunodetection of proteins
Antibodies against NtMAP65-1a (anti-MAP65) and Thr-579-phosphorylated NtMAP65-1a (anti-pT579MAP65) were prepared using the synthetic peptides SGSEHSPSTP and SGSEHSPST(PO 3 H 2 )P (residues 571-580 of NtMAP65-1a), respectively, as antigens. Specific antibodies were affinity-purified with the appropriate antigenic oligopeptide . Monoclonal T7 antibodies and GFP antibodies were purchased from Novagen and Clontech, respectively.
Preparation of tubulin from porcine brains for the MT-bundling assay in vitro
Tubulin was purified from porcine brains as described by Itoh et al. (1997) . Paclitaxel-stabilized MTs were also prepared and subjected to dark-field microscopy as described by Itoh et al. (1997) .
MT-bundling assay in vitro
NtMAP65-1a or phosphorylated NtMAP65-1a at various concentrations was mixed with 2 µM paclitaxel-stabilized MTs. The mixture was incubated for 5 min at room temperature and then centrifuged at 4500 × g for 5 min at 25°C. The resultant supernatants and pellets were subjected to SDS-PAGE. Bands of tubulin were stained with Coomassie brilliant blue, and the relative amounts of tubulin in pellets were calculated with the NIH Image program (http://rsb.info.nih.gov/nih-image), after scanning of gel images as PICT files.
Fluorescence microscopy
All techniques for microscopic analysis were described previously , with the exception that BY-2 cells were fixed in 3.7% paraformaldehyde in PM buffer (0.1 M PIPES at pH 6.9, 1 mM EGTA, 0.5 mM MgSO 4 ) instead of 3.7% formaldehyde in sodium phosphate buffer. (Left) In this scheme, NtMAP65-1 stabilizes and maintains phragmoplast structures via its strong ability to bundle MTs during cytokinesis. During cytokinesis, in the midzone of the phragmoplast at sites where the components of the NACK-PQR pathway, including NRK1/NTF6 MAPK, are activated, NtMAP65-1 is phosphorylated by NRK1/NTF6 at Thr-579, and this phosphorylation results in localized suppression of its MTbundling activity. (Right) Such suppression increases the instability of the organized MT-containing structure and the rate of MT turnover, which results in accelerated expansion of the phragmoplast.
